Fed. Circ. Nixes $29M HemCon Hit In Polymer Patent Suit
The Federal Circuit on Monday overturned a $29 million damages award against HemCon Medical Technologies Inc. for allegedly infringing Marine Polymer Technologies Inc.'s patent for a polymer that accelerates hemostasis, saying...To view the full article, register now.
Already a subscriber? Click here to view full article